Annual ROE
-14.42%
+9.40%+39.46%
December 31, 2023
Summary
- As of February 10, 2025, ABIO annual return on equity is -14.42%, with the most recent change of +9.40% (+39.46%) on December 31, 2023.
- During the last 3 years, ABIO annual ROE has risen by +6.51% (+31.10%).
Performance
ABIO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-20.18%
-4.11%-25.58%
June 30, 2024
Summary
- As of February 10, 2025, ABIO quarterly return on equity is -20.18%, with the most recent change of -4.11% (-25.58%) on June 30, 2024.
- Over the past year, ABIO quarterly ROE has dropped by -6.38% (-46.23%).
Performance
ABIO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ABIO ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +39.5% | -46.2% |
| 3 y3 years | +31.1% | +38.1% |
| 5 y5 years | +89.0% | +38.1% |
ABIO ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +162.5% | +48.3% | +69.1% |
| 5 y | 5-year | at high | +399.6% | +48.3% | +230.1% |
| alltime | all time | -128.3% | +5587.2% | -118.9% | +2525.0% |
ARCA Biopharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | -20.18%(+25.6%) |
| Mar 2024 | - | -16.07%(+16.4%) |
| Dec 2023 | -14.42%(-39.5%) | -13.80%(+1.4%) |
| Sep 2023 | - | -13.61%(-11.8%) |
| Jun 2023 | - | -15.43%(-18.1%) |
| Mar 2023 | - | -18.84%(-15.9%) |
| Dec 2022 | -23.82%(-37.1%) | -22.39%(-27.6%) |
| Sep 2022 | - | -30.92%(-7.8%) |
| Jun 2022 | - | -33.52%(-1.8%) |
| Mar 2022 | - | -34.12%(+3.6%) |
| Dec 2021 | -37.85%(+80.8%) | -32.92%(+1.0%) |
| Sep 2021 | - | -32.61%(+13.8%) |
| Jun 2021 | - | -28.65%(-0.9%) |
| Mar 2021 | - | -28.91%(-15.7%) |
| Dec 2020 | -20.93%(-70.9%) | -34.29%(+9.6%) |
| Sep 2020 | - | -31.28%(-48.4%) |
| Jun 2020 | - | -60.62%(-5.9%) |
| Mar 2020 | - | -64.42%(-3.3%) |
| Dec 2019 | -72.04%(-45.2%) | -66.62%(-9.2%) |
| Sep 2019 | - | -73.33%(-11.0%) |
| Jun 2019 | - | -82.42%(-10.5%) |
| Mar 2019 | - | -92.07%(-2.6%) |
| Dec 2018 | -131.48%(-26.9%) | -94.57%(-16.0%) |
| Sep 2018 | - | -112.60%(-6.7%) |
| Jun 2018 | - | -120.65%(-9.9%) |
| Mar 2018 | - | -133.88%(+4.0%) |
| Dec 2017 | -179.79%(+142.4%) | -128.71%(+20.4%) |
| Sep 2017 | - | -106.93%(+15.9%) |
| Jun 2017 | - | -92.23%(+31.2%) |
| Mar 2017 | - | -70.29%(+21.8%) |
| Dec 2016 | -74.18%(+146.8%) | -57.69%(+22.0%) |
| Sep 2016 | - | -47.30%(+26.6%) |
| Jun 2016 | - | -37.36%(+19.2%) |
| Mar 2016 | - | -31.34%(-7.6%) |
| Dec 2015 | -30.06%(-54.3%) | -33.90%(-13.0%) |
| Sep 2015 | - | -38.98%(-17.4%) |
| Jun 2015 | - | -47.18%(-25.6%) |
| Mar 2015 | - | -63.38%(+19.0%) |
| Dec 2014 | -65.73%(+47.6%) | -53.24%(-2.2%) |
| Sep 2014 | - | -54.45%(+7.6%) |
| Jun 2014 | - | -50.60%(+15.7%) |
| Mar 2014 | - | -43.74%(-9.7%) |
| Dec 2013 | -44.54%(-70.0%) | -48.44%(+11.8%) |
| Sep 2013 | - | -43.33%(-21.0%) |
| Jun 2013 | - | -54.87%(-56.3%) |
| Mar 2013 | - | -125.67%(-0.2%) |
| Dec 2012 | -148.61%(+58.8%) | -125.89%(+1.9%) |
| Sep 2012 | - | -123.50%(-1.3%) |
| Jun 2012 | - | -125.19%(+60.7%) |
| Mar 2012 | - | -77.88%(-13.9%) |
| Dec 2011 | -93.58%(-24.7%) | -90.41%(+5.1%) |
| Sep 2011 | - | -86.05%(+5.1%) |
| Jun 2011 | - | -81.86%(-24.1%) |
| Mar 2011 | - | -107.80%(+20.8%) |
| Dec 2010 | -124.35% | -89.25%(-34.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2010 | - | -135.61%(-3.2%) |
| Jun 2010 | - | -140.12%(-18.2%) |
| Mar 2010 | - | -171.38%(+197.8%) |
| Dec 2009 | -123.29%(-342.2%) | -57.55%(-154.0%) |
| Sep 2009 | - | 106.55%(+2221.4%) |
| Jun 2009 | - | 4.59%(-81.3%) |
| Mar 2009 | - | 24.59%(-137.8%) |
| Dec 2008 | 50.90%(-384.5%) | -65.01%(-10.2%) |
| Sep 2008 | - | -72.38%(+1.1%) |
| Jun 2008 | - | -71.58%(+219.1%) |
| Mar 2008 | - | -22.43%(+31.5%) |
| Dec 2007 | -17.89%(-91.3%) | -17.06%(-78.7%) |
| Sep 2007 | - | -80.04%(-2.8%) |
| Jun 2007 | - | -82.38%(-29.5%) |
| Mar 2007 | - | -116.83%(-3.3%) |
| Dec 2006 | -206.23%(+47.4%) | -120.84%(+49.0%) |
| Sep 2006 | - | -81.12%(+3.0%) |
| Jun 2006 | - | -78.79%(-5.9%) |
| Mar 2006 | - | -83.71%(-18.3%) |
| Dec 2005 | -139.93%(-9.0%) | -102.51%(+14.0%) |
| Sep 2005 | - | -89.89%(+14.8%) |
| Jun 2005 | - | -78.29%(+10.8%) |
| Mar 2005 | - | -70.64%(-26.5%) |
| Dec 2004 | -153.72%(-72.2%) | -96.12%(-8.7%) |
| Sep 2004 | - | -105.23%(-18.7%) |
| Jun 2004 | - | -129.41%(-27.5%) |
| Mar 2004 | - | -178.47%(-51.0%) |
| Dec 2003 | -553.42%(-32.5%) | -364.40%(-26.4%) |
| Sep 2003 | - | -495.30%(+36.7%) |
| Jun 2003 | - | -362.32%(+5.2%) |
| Mar 2003 | - | -344.37%(-35.0%) |
| Dec 2002 | -820.09%(+168.6%) | -529.73%(+90.7%) |
| Sep 2002 | - | -277.73%(-15.3%) |
| Jun 2002 | - | -328.07%(+11.2%) |
| Mar 2002 | - | -295.01%(+36.3%) |
| Dec 2001 | -305.27%(+157.6%) | -216.45%(+13.4%) |
| Sep 2001 | - | -190.90%(+13.1%) |
| Jun 2001 | - | -168.84%(+28.6%) |
| Mar 2001 | - | -131.28%(+10.1%) |
| Dec 2000 | -118.49%(+145.9%) | -119.19%(+38.2%) |
| Sep 2000 | - | -86.24%(+18.9%) |
| Jun 2000 | - | -72.53%(+20.9%) |
| Mar 2000 | - | -59.99%(+25.4%) |
| Dec 1999 | -48.18%(+62.3%) | -47.84%(+16.2%) |
| Sep 1999 | - | -41.18%(+3.7%) |
| Jun 1999 | - | -39.72%(+12.8%) |
| Mar 1999 | - | -35.21%(+20.2%) |
| Dec 1998 | -29.68%(+60.5%) | -29.30%(+27.8%) |
| Sep 1998 | - | -22.93%(+22.4%) |
| Jun 1998 | - | -18.73%(+7.9%) |
| Mar 1998 | - | -17.36%(-0.3%) |
| Dec 1997 | -18.49%(-71.5%) | -17.42%(-0.3%) |
| Sep 1997 | - | -17.48%(-47.3%) |
| Jun 1997 | - | -33.17%(-2.2%) |
| Mar 1997 | - | -33.93% |
| Dec 1996 | -64.86% | - |
FAQ
- What is ARCA biopharma annual return on equity?
- What is the all time high annual ROE for ARCA biopharma?
- What is ARCA biopharma annual ROE year-on-year change?
- What is ARCA biopharma quarterly return on equity?
- What is the all time high quarterly ROE for ARCA biopharma?
- What is ARCA biopharma quarterly ROE year-on-year change?
What is ARCA biopharma annual return on equity?
The current annual ROE of ABIO is -14.42%
What is the all time high annual ROE for ARCA biopharma?
ARCA biopharma all-time high annual return on equity is 50.90%
What is ARCA biopharma annual ROE year-on-year change?
Over the past year, ABIO annual return on equity has changed by +9.40% (+39.46%)
What is ARCA biopharma quarterly return on equity?
The current quarterly ROE of ABIO is -20.18%
What is the all time high quarterly ROE for ARCA biopharma?
ARCA biopharma all-time high quarterly return on equity is 106.55%
What is ARCA biopharma quarterly ROE year-on-year change?
Over the past year, ABIO quarterly return on equity has changed by -6.38% (-46.23%)